PATIENTS AND METHODS
Ethics Committee approval was obtained. The patients had been referred for oral surgical procedures and required sedation because of anxiety, some having a history of failure of treatment without sedation. Patients with a serious medical disease, receiving regular psychotropic drugs or with mask phobia were excluded from the trial. approximate balance of the numbers of each sex treated, the two techniques were used alternatively in male and in female patients. The same anaesthetist (G.D.P.) administered sedation in all cases. Patients were instructed to have a light breakfast on the day of treatment and to arrange to have an escort home. All treatments were given in the morning. Informed written consent was obtained, followed by a medical history and clinical assessment. Anxiety was assessed using the Corah dental anxiety scale [8] and a 10-cm visual analogue scale. Co-ordination was tested with a board on which the patient tapped target areas with a stylus for 10 s [9] .
The dental chair was adjusted so that the back was at an angle of 25° to the horizontal. ECG electrodes and a pulse oximeter were applied to the patient and arterial pressure was measured by oscillotonometry.
Midazolam 1 mg ml" 1 was given via a cannula in a vein in the hand. An initial dose of 2.5 mg was followed by supplements of not more than 1 mg per minute until sedation was judged adequate. At this point local analgesic was injected by the dental surgeon. Verrill's sign of ptosis [10] was often present, but was not used as a guide because many patients preferred to close the eyes voluntarily during initial induction of sedation. Its presence or absence was noted when the patients opened the eyes during conversation during operation.
In the isoflurane group oxygen 7 litre min" 1 passed through a prototype 0.2-1.4% Penlon vaporizer to a reservoir bag and Dupaco nasal mask. The patient was familiarized with the mask and nasal breathing technique with oxygen alone, then isoflurane was introduced in a concentration of 0.2 % and increased by 0.1 % each 30s to 0.6 %, the concentration thereafter being increased or decreased until sedation was judged adequate. Heart rate and pulse oximeter readings (Sa O2 ) were noted at 5-min intervals. The dose of midazolam and concentration of isoflurane were also noted, as was the time at which local analgesic was injected. After treatment the dental chair was returned to the sitting position and after 2 min the patient was transferred by chair to a couch in the recovery area. The dental surgeon completed a form giving his clinical assessment after the surgery.
Immediately after operation the patient's heart rate and arterial pressure were measured and patients in the isoflurane group gave an opinion on odour. Ten minutes after operation, if the patient could sit up comfortably, the tapping test was performed and, if the result exceeded 90 % of the preoperative value, the patient tried to stand. If these tests were satisfactory, a finger-nose test with eyes closed was performed before an attempt at a 10-m walk in a straight line, a turn and return. Tests were repeated at 5-min intervals until the walking test had been completed successfully; recovery times were calculated to this point.
An assessment of anxiety was made using a visual analogue scale before discharge and note made of the patient's memory for leaving the dental chair, the dental procedure and injections of local analgesic. Recalled injections were graded as acceptable, unpleasant or painful. Finally the patient gave a general opinion of the procedure.
Side effects over two days after operation were assessed by means of a separate form based on that described by Smith and Young [11] .
RESULTS
Eighty patients participated in the trial: nine men and 31 women in the midazolam group and eight men and 32 women in the isoflurane group. Forty-four patients had surgical removal of wisdom teeth; 14 of these required extraction of teeth in more than one quadrant. Eighteen patients had multiple extractions and 14 others required apicectomies, two curettage, one excision of a cyst and another, closure of an oroantral fistula. The range of operations was similar in the two groups.
The mean dose of midazolam was 5.2 mg (range 3-9 mg). The dose of midazolam was unrelated to the weight of the patient (Pearson r = 0.147). In the second group the concentrations delivered by the vaporizer, after initial induction, ranged from 0.4% to 1.2%. The mean concentration at 20 min (or 15 min for three patients in whom the operation finished before 20 min) was 0.72%. Verbal contact was maintained in all patients given midazolam. One patient in the isoflurane group became excessively drowsy 15 min after induction, at a vaporizer concentration of 0.8%. Conscious sedation returned within 30 s of ceasing administration of isoflurane and sedation was maintained with 0.4-0.6 % isoflurane.
The groups were comparable for age, weight and preoperative anxiety (table I). Seven patients had a Corah score greater than 17, a degree approaching phobia, and these patients needed reassurance to sit in the dental chair. There was a significant correlation {r = 0.476, P < 0.01) between the Corah and preoperative visual analogue scores. The visual analogue anxiety scores decreased after operation to similar values in each group (table I) .
The durations of surgery were similar, but the time for induction of sedation was significantly longer in the isoflurane group (P < 0.001). The recovery time to completion of the walking test was significantly longer in the midazolam group (P< 0.001).
Pre-and postoperative arterial pressure and heart rates were comparable, but during the operation mean heart rate at 15 min in the midazolam group (97.1 beat min" 1 ) was greater than the preoperative mean (86.0 beat min" 1 ) and greater than the mean at 15 min in the isoflurane group (88.8 beat min" 1 ) (P < 0.001 in each case; Mann-Whitney U test). No arrhythmias were observed and heart rate always exceeded 58 beat min" 1 . Mean Sa O2 in patients breathing isoflurane in oxygen was significantly greater than that in the midazolam group (P < 0.001; Mann-Whitney U test). Sa o , always exceeded 90% in the midazolam patients, but nine of these patients had intermittent Sa Oj values of 90-94%. All but one were heavier than the group average (mean weight 77.6 (12.5) kg; group mean weight 64.8 (12.1) kg).
In the opinion of the dental surgeon, five patients gave an exaggerated response to injection of local analgesic in the isoflurane group, but none did so in the midazolam group (table II) . With one very anxious patient (Corah score of 16) in the isoflurane group, conditions were judged inadê quate. The dental surgeon judged the patients as more frequently calm and oriented after midazolam and more frequently euphoric after isoflurane. In both groups the patients' mean estimate of the duration of the operation was approximately 50% of the true value (table III) . Amnesia for injection of local analgesic was more likely after midazolam. Fifteen patients in the isoflurane group reported that the injections of local analgesic were unpleasant or painful, compared with six in the midazolam group (P < 0.05). Both techniques were rated as satisfactory in the patients' general opinion and only one patient of each group said that she would not wish to have the technique again; with midazolam, the patient said she had felt "unpleasantly weird", while with isoflurane the patient said she disliked the smell. While accepting the technique, another three patients (one midazolam and two isoflurane) would have preferred general anaesthesia; one in the isoflurane group would have preferred an injection technique.
Postoperative questionnaires were returned by 31 patients in the midazolam group and 34 in the isoflurane group (table IV) . There was a similar high frequency of side effects in both groups. To give an index of the overall incidence of side effects, a score of 1 was given for each day a side effect was reported. The mean scores were similar in the two treatment groups.
The overall results were analysed to determine any significant trends between anxiety and other factors. There was no significant relationship between the concentration of isofiurane used and the patient's anxiety, but the dose of midazolam was greater in patients with more anxiety as assessed on the preoperative visual analogue scale (r = 0.454, P < 0.01). The total side effects score was related to postoperative anxiety (VAS) (rank correlation: r = 0.304, P < 0.05). work in patients who are known to react adversely or have developed tolerance to benzodiazepines [16] , or in patients who have an excessive fear of i.v. injections. Sedation with isofiurane is contraindicated in patient with a mask phobia and is less convenient for operations on anterior maxillary teeth when the Dupaco mask can be a hindrance to the surgeon. For other occasions, the choice between isofiurane and midazolam depends on the relative merits of more rapid induction with midazolam and more rapid recovery with isofiurane. DISCUSSION Lindsay and his colleagues reported that 31 % of adults would prefer to receive sedation or anaesthesia for dental treatment [12] . We found that both midazolam and isofiurane gave satisfactory sedation, but identified some differences.
Midazolam has the advantage of a wide therapeutic ratio between sedative and anaesthetic doses. Conscious sedation, as defined by the maintenance of verbal contact [13] was achieved readily. As midazolam produces a peak effect early after injection, patients are generally well sedated at the time of the injection of local analgesic and less likely to report injections as unpleasant. We found that the dose of midazolam required was related to anxiety rather than weight of the patient, and we would not recommend the use of any weight-related dose in case this leads to a relative overdose and hypoxia.
Isofiurane has a small therapeutic ratio, so care is required to achieve conscious sedation. Because of this, and the odour of isofiurane, induction of sedation is slower and the degree of sedation and amnesia at the time of injection of local analgesic may not be optimal. A high degree of air dilution is inevitable during dental sedation [14] and this adds to the difficulty in selecting an appropriate vaporizer concentration. However, the degree of sedation can be reduced rapidly and this flexibility is lacking with midazolam. Another advantage of isofiurane is that recovery is more rapid than with midazolam and this may be important, as some patients ignore advice and return to work or drive cars shortly after treatment [15] .
It would appear reasonable to restrict isofiurane sedation to circumstances when a second qualified person is present in addition to the operator. Isofiurane sedation may be considered for dental
